Administered Prices: Hearings, Eighty-fifth Congress, First Session Pursuant to S. Res. 56U.S. Government Printing Office, 1957 - 232 páginas |
Dentro del libro
Resultados 1-3 de 72
Página 15658
... consideration the therapeutic and marketing potentiality of any invention described in such applications . ( c ) ... consideration of Bristol's contributions set forth in Item 3 , and in consideration of royalties to be paid by Eristol to ...
... consideration the therapeutic and marketing potentiality of any invention described in such applications . ( c ) ... consideration of Bristol's contributions set forth in Item 3 , and in consideration of royalties to be paid by Eristol to ...
Página 16358
... consideration therefor which can be shared with Pfizer , Pfizer will be entitled , if it is the owner of any patent hereunder , to keep for itself all the consideration received by it on the first three licenses which it issues to ...
... consideration therefor which can be shared with Pfizer , Pfizer will be entitled , if it is the owner of any patent hereunder , to keep for itself all the consideration received by it on the first three licenses which it issues to ...
Página 16402
... consideration for and within ten ( 10 ) days following the performance by Union of its obligations under Paragraph 2 . ( b ) The sum of Ten Thousand Dollars ( $ 10,000.00 ) in consideration for and within ten ( 10 ) days following the ...
... consideration for and within ten ( 10 ) days following the performance by Union of its obligations under Paragraph 2 . ( b ) The sum of Ten Thousand Dollars ( $ 10,000.00 ) in consideration for and within ten ( 10 ) days following the ...
Contenido
Page | 15331 |
Foreign license agreements of Bristol Laboratories and related | 15458 |
ExhibitsContinued | 15726 |
Otras 22 secciones no mostradas
Otras ediciones - Ver todas
Términos y frases comunes
added to Schedule Allen & Hanburys amended America American Cyanamid Company and/or annexed hereto antibiotic substance aplastic anemia Application being filed Article FOURTH BRISTOL hereby BRISTOL LABORATORIES INC chloramphenicol Chloromycetin Chlortetracycline commensurate to pending confidential know-how corporation organized cycline DAVIS & COMPANY deemed to mean drug duly authorized effect fermentation filed commensurate Filing Date hereby agrees hereinafter defined hereinafter referred HOECHST Issue Date January July laws LEPETIT letter license agreement Licensed Cyanamid Patents Licensed Patents Licensed Products Finished LICENSEE LICENSEE'S Licensor manufacture organized and existing Paragraph Parke Davis Parke-Davis parties hereto Patent Applications Serial patent rights payable pending United penicillin Pfizer priority date priority date thereof products containing pursuant respect retailers rights and licenses royalties sales of Licensed Sales Price secret formulae secret processes sublicense subsidiaries or affiliates Supplemental Agreement termination Territory Tetracycline therapeutically active ingredients third party trade trademarks United States dollars United States Patent WHEREAS York